טוען...
A Novel Calculator for Esophageal Adenocarcinoma Accurately Predicts Overall Survival Benefit from Neoadjuvant Chemoradiation
INTRODUCTION: Our group recently published that patients with clinically node negative (cN−) esophageal adenocarcinoma do not derive an overall survival (OS) benefit from neoadjuvant chemoradiation (nCRT) compared to clinically node positive (cN+) patients. The aim of this study was to develop a cal...
שמור ב:
| הוצא לאור ב: | J Am Coll Surg |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5836490/ https://ncbi.nlm.nih.gov/pubmed/28147252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jamcollsurg.2017.01.043 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|